Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/1999
07/06/1999US5919654 Secretion signal gene and expression vector containing it
07/06/1999US5919653 A recombinantly altered nucleotide sequence that codes for a neurotransmitter protein; treatment of epilepsy, stroke, multiple sclerosis, spinal cord injury, and other nervous system disorders
07/06/1999US5919652 Anticarcinogenic agents, antitumor agents for vectors used in gene therapy
07/06/1999US5919651 Expression of polypeptides in yeast
07/06/1999US5919649 Dna encoding a recombinant protein capable of activating transcription; in response to cyclic adenosine 3',5'-monosphosphate; controlling protein expression
07/06/1999US5919648 One step conversion of cephalosporin c or derivative into 7-aminocephalosporanic acid or derivative using aminohydrolase from psuedomonas vesicularis b965; for cephalothin, cephaloridine, and cefuroxime synthesis
07/06/1999US5919638 Nucleotide sequences for primers, probes, gene therapy, antisense/antitumor/antimetastasis agents
07/06/1999US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand
07/06/1999US5919636 Genetic engineered human embryonic kidney cells containing mammmalian scavenger gene
07/06/1999US5919635 Using a genetic engineered receptor
07/06/1999US5919630 Detection of nucleic acids by fluorescence quenching
07/06/1999US5919627 Microsomal glutathione-S-transferase
07/06/1999US5919626 Simple and cost efficient method by coating solid phase with mercapto-silane or epoxy-silane and coupling unmodified 3' hydroxy or 5' hydroxy terminal nucleic acid to silane
07/06/1999US5919625 Detecting rna in test samples; mixing test sample with a nucleic acid standard encapsidated in bacteriophage viral coat protein, isolating and assaying rna, using non-bacteriophage rna standards
07/06/1999US5919623 Forming heterduplex molecules by hybridizing single strands of target dna with non-mutant reference dna; adding mis-match binding protein and treating with exonuclease to degrade unprotected duplex; detecting presence/location of mutation
07/06/1999US5919622 Vessel with lid to hold liquid, thermostat element, disposable heating element in lid; nucleic acid preparation and amplification in a single vessel
07/06/1999US5919619 Preferentally suppressing gene expression of target proteins by synthesizing and then hybridizing complementary oligonucleotide to subsequence of specific messenger ribonucleic acid in cell
07/06/1999US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them
07/06/1999US5919462 Nucleic acid fragments derived from the HIV-1 virus genome, corresponding peptides and their applications as reagents for evaluation of the risk of maternofoetal transmission of HIV-1
07/06/1999US5919458 Immunogen comprising particles of non-infectious human immunodeficieny virus having rna packaging defects in physiologically aceptable vehicle
07/06/1999US5919456 IL-13 receptor specific chimeric proteins
07/06/1999US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
07/06/1999US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
07/06/1999US5919442 Hyper comb-branched polymer conjugates
07/06/1999CA2233593A1 Novel protein molecules and uses therefor
07/06/1999CA2182521C Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
07/06/1999CA2134477C Analysis based on flow restriction
07/06/1999CA2134475C Polynucleotide amplification analysis using a microfabricated device
07/06/1999CA2134474C Microfabricated sperm handling devices
07/06/1999CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto
07/06/1999CA2086417C Melanin production by transformed organisms
07/06/1999CA2058785C Method of producing proteins with fviii activity and/or fviii derivatives
07/06/1999CA2004764C Ancrod proteins, their preparation and use
07/06/1999CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes
07/06/1999CA1340629C T-cell receptor gene located within alpha locus and dna constructions
07/06/1999CA1340628C T7 dna polymerase
07/06/1999CA1340627C T4 glycoprotien fragments and use of fragments of t4 in the treatment of aids
07/06/1999CA1340625C Cloned cardionatrin cdna
07/06/1999CA1340624C Modified vaccinia virus and methods for making and using the same
07/05/1999WO1999038976A2 Human growth factor homologs
07/05/1999CA2317812A1 Human growth factor homologs
07/01/1999WO1999032663A2 High throughput assay system
07/01/1999WO1999032661A1 Qtl mapping in plant breeding populations
07/01/1999WO1999032658A1 Overlapping nucleotide sequences, and their use for detecting xenohormones and in pharmaceutical compositions
07/01/1999WO1999032654A1 Direct rt-pcr on oligonucleotide-immobilized pcr microplates
07/01/1999WO1999032648A1 Recombinant rhabdovirus containing a heterologous fusion protein
07/01/1999WO1999032647A1 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
07/01/1999WO1999032646A1 Equine infectious anaemia virus (eiav) based
07/01/1999WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/01/1999WO1999032644A2 Prostate cancer gene
07/01/1999WO1999032643A2 Mood disorder gene
07/01/1999WO1999032642A2 Method for reduction of transgene copy number
07/01/1999WO1999032641A1 A process for site-directed integration of multiple copies of a gene in a mould
07/01/1999WO1999032639A1 Receptor tyrosine kinase, ar-1, is a regulator of angiogenesis
07/01/1999WO1999032638A1 Process for producing dihydroxyacetone 3-phosphate
07/01/1999WO1999032637A1 Human signal transduction serine/threonine kinase
07/01/1999WO1999032636A1 Biodegradation of explosives
07/01/1999WO1999032635A1 Acetyl-coa-carboxylase from candida albicans
07/01/1999WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use
07/01/1999WO1999032633A1 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
07/01/1999WO1999032632A1 Novel embryo-derived interleukin related factor molecules and uses therefor
07/01/1999WO1999032631A1 CHEMOKINE OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
07/01/1999WO1999032630A1 Herbicide binding proteins and transgenic plants containing them
07/01/1999WO1999032629A1 Tigirr dna and polypeptides
07/01/1999WO1999032628A2 Wip, a wasp-associated protein
07/01/1999WO1999032627A2 The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase
07/01/1999WO1999032626A1 Sigirr dna and polypeptides
07/01/1999WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use
07/01/1999WO1999032624A1 Human proteins responsible for nedd8 activation and conjugation
07/01/1999WO1999032623A1 Human sel-10 polypeptides and polynucleotides that encode them
07/01/1999WO1999032622A2 Semaphorin zsmf-3
07/01/1999WO1999032621A2 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof
07/01/1999WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof
07/01/1999WO1999032619A1 Genetic inhibition by double-stranded rna
07/01/1999WO1999032618A1 Non-bacterial cloning in delivery and expression of nucleic acids
07/01/1999WO1999032617A2 Expression cloning in filamentous fungi
07/01/1999WO1999032616A2 Method for isolating short and long-chain nucleic acids
07/01/1999WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
07/01/1999WO1999032614A1 Secreted proteins and polynucleotides encoding them
07/01/1999WO1999032610A1 Human nucleotide pyrophosphohydrolase-2
07/01/1999WO1999032608A1 MULTIPLE DRUG RESISTANCE GENE atrD OF $i(ASPERGILLUS NIDULANS)
07/01/1999WO1999032606A2 Neural precursor cells, method for the production and use thereof in neural defect therapy
07/01/1999WO1999032605A1 Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
07/01/1999WO1999032604A1 Linoleate isomerase
07/01/1999WO1999032603A1 Bacterial nitrite oxidizer and method of use thereof
07/01/1999WO1999032520A1 Method for quantitating denatured ldls
07/01/1999WO1999032519A1 Novel g protein-coupled receptor
07/01/1999WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
07/01/1999WO1999032516A2 Pharmaceutical compositions containing the long pentraxin ptx3
07/01/1999WO1999032514A2 Sag: sensitive to apoptosis gene
07/01/1999WO1999032513A1 Protein binding polypeptides
07/01/1999WO1999032505A1 MULTIPLE DRUG RESISTANCE GENE atrC OF $i(ASPERGILLUS NIDULANS)
07/01/1999WO1999032145A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors
07/01/1999WO1999032143A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium
07/01/1999WO1999032142A1 Beta-lipotropin and uses thereof
07/01/1999WO1999032141A1 Ifnar2/ifn complex
07/01/1999WO1999032135A1 Keratinocyte growth factor-2 formulations
07/01/1999WO1999031990A1 Carbohydrate oxidase and use thereof in baking
07/01/1999WO1999031969A2 Transgenic animal model for degenerative diseases of cartilage
07/01/1999WO1999025861A3 Adenovirus vectors and method for reducing homologous recombination phenomena